Hypertension

High blood pressure increases a patient's risk of heart attack, stroke and other diseases. Most people with hypertension have no symptoms. The Centers for Disease Control and Prevention (CDC) says nearly half of U.S. adults have hypertension, or high blood pressure, and only about 1 in 4 of those individuals has their hypertension under control. The World Health Organization (WHO) expects the epidemic of hypertension world-wide will exceed 1.56 billion people by 2025. Major efforts are underway to better control this primary risk factor through screenings, medication and invasive procedures such as renal denervation in severely uncontrolled patients.

FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck
Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.
FDA approves new hypertension drug months after Idorsia reacquired rights for $343M
Aprocitentan, sold under the brand name Tryvio, is approved for patients with high blood pressure who are already taking other antihypertensive drugs.
World’s first patient treated with new implantable device for pulmonary hypertension
The procedure, performed on Feb. 14, was part of an early feasibility trial developed with help from the FDA.
Flexitarian diet, a plant-based option that includes small amounts of meat, linked to key cardiovascular benefits
The study, designed to compare flexitarians with vegans and omnivores, focused on young and middle-aged adults in good health who had been following the same diet for at least one full year.
Salt substitutes reduce hypertension risk by up to 40%
Many patients do not want to limit their salt intake, even when a doctor tells them the numerous health benefits. Salt substitutes may represent another way forward.

The Pulnovo pulmonary artery denervation catheter. In February 2021, the devices was granted the U.S. Food and Drug Administration (FDA) breakthrough device designation. #TCT2022 #PAH

Pulmonary artery denervation shows promise to treat pulmonary arterial hypertension

Pulmonary artery denervation may offer a new therapy option for this difficult-to-treat population.

September 21, 2022

Positive data was presented on the first-generation Symplicity (left) long-term outcomes and from the Recor ultrasound renal denervation system pivotal trial at TCT 2022. #TCT #TCT2022

Renal denervation lowered blood pressure in two late-breaking TCT trials

Results from the Medtronic SYMPLICITY HTN-3 trial long-term results and the pivotal RADIANCE II trial for the Recor ultrasound renal denervation system lowered blood pressure effectively in drug-resistant patients.

September 19, 2022

Cardiologists sound the alarm as ‘staggering’ new data suggest CVD rates in the U.S. will rise dramatically

New data from the CDC and U.S. Census Bureau show just how bad CVD rates could get in the next few decades. Specialists agree that a lot of work is needed to help keep these estimates from becoming a reality.

August 2, 2022

High blood pressure more than doubles risk of COVID-19 hospitalization

Adults that received three doses of an mRNA COVID vaccine were 2.6 times as likely to be hospitalized if they also had high blood pressure.

July 22, 2022

RAAS inhibitors lower risk of aneurysm rupture among patients with high blood pressure

Researchers also noted that uncontrolled hypertension, exposure to second-hand smoke and untreated type 2 diabetes were all associated with a greater rupture risk.

June 3, 2022

cocaine heart failure HFrEF LVEF hospitalizations beta-blockers hypertension cardiology

How cocaine use affects outcomes for hospitalized heart failure patients

When cocaine users are hospitalized for heart failure, what should physicians expect? Are beta-blockers an effective treatment strategy?

June 3, 2022

Renal denervation is associated with improved blood pressure (BP) control and a reduced risk of adverse cardiovascular outcomes, according to two late-breaking clinical trials presented at EuroPCR 2022 in Paris. Both clinical trials focused on three-year data related to Medtronic’s Symplicity Spyral Renal Denervation (RDN) System, which was designed to lower BP through the use of a curling catheter that ablates overactive nerves.

Renal denervation improves blood pressure control, lowers risk of adverse cardiovascular outcomes

Two late-breaking clinical trials at EuroPCR 2022 in Paris focused on the potential benefits of renal denervation.

May 17, 2022

Arterial stiffness may predict type 2 diabetes risk better than high blood pressure

Researchers tracked data from more than 11,000 adult patients, sharing their findings in Hypertension.

May 16, 2022

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Hypertension

FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck

FDA approves new hypertension drug months after Idorsia reacquired rights for $343M

World’s first patient treated with new implantable device for pulmonary hypertension

Flexitarian diet, a plant-based option that includes small amounts of meat, linked to key cardiovascular benefits

Salt substitutes reduce hypertension risk by up to 40%

Around the web